Search results
CRYOcheck Factor VIII Inhibitor Kit, frozen
The CE marked kit is ideal for laboratories seeking to standardize sample preparation to limit variability in their MNBA. Each kit contains five vial sets—enough to prepare five patient samples—including positive and negative FVIII inhibitor controls Excellent repeatability and reproducibility; suitable for multi-center clinical studies Excellent linearity across a broad reportable range Convenient frozen format—ready to use within minutes, no reconstitution errors Further information available here Please find the safety data sheet for the controls included in the kit by clicking the MSDS download button below. Please find the safety data sheet for the included component IB-PNP here . Please find the safety data sheet for the included component IB-BSA here .
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Collagen
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Arachidonic Acid
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
ADP Assay for Platelet Aggregation
Investigation of congenital (e.g. Glanzmann’s thrombasthenia, Bernard-Soulier, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma, hepatic or renal failure). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
GFC-Test
Test reagents for quick and efficient measurement of the Global Fibrinolytic Capacity with Hyphen BioMed lysis timer .
Tissue Plasminogen Activator (tPA), anti-human, sheep, IgG, affinity purified
Anti-sheep, donkey, IgG, affinity purified, Peroxidase conjugated
Anti-rabbit, sheep, IgG, affinity purified, Peroxidase conjugated
Anti-sheep, donkey, IgG, affinity purified, biotinylated